We could not find any results for:
Make sure your spelling is correct or try broadening your search.
NEW BRUNSWICK, N.J., Feb. 23 /PRNewswire-FirstCall/ -- Johnson & Johnson will participate in the RBC Capital Markets' Health Care Conference on Tuesday, March 2, 2010, at the New York Palace...
Cordis to Receive $1.725 Billion BRIDGEWATER, N.J., Feb. 1 /PRNewswire/ -- Cordis Corporation, a Johnson & Johnson company, announced today that it has reached an agreement with Boston Scientific...
2009 Fourth-Quarter Sales of $16.6 Billion increased 9.0%; EPS was $0.79 2009 Full-Year Sales of $61.9 Billion decreased 2.9%; Full-Year EPS was $4.40 Excluding Special Items, 2009 Fourth-Quarter...
NEW BRUNSWICK, N.J., Jan. 19 /PRNewswire-FirstCall/ -- Johnson & Johnson will host an analyst meeting at 8:30 a.m. (Eastern Time) on Tuesday, January 26, 2010, to discuss fourth-quarter and...
TITUSVILLE, N.J., Dec. 10 /PRNewswire/ -- Treatment with once-monthly INVEGA® SUSTENNA(TM) is not inferior to treatment with bi-weekly RISPERDAL® CONSTA®, according to new data from a...
ORLANDO, Fla., Nov. 11 /PRNewswire-FirstCall/ -- Contact lenses prescribed for longer replacement intervals can lead to more extreme over wear (stretching) that could lead to undesirable...
Telescope Prosthesis for End-Stage Macular Degeneration Highlighted SARATOGA, Calif., Oct. 20 /PRNewswire/ -- VisionCare Ophthalmic Technologies, Inc., a developer of advanced visual prosthetic...
Patients with Active Rheumatoid Arthritis Receiving SIMPONI Demonstrated Sustained Improvements in Signs and Symptoms Through One Year PHILADELPHIA, Oct. 19 /PRNewswire/ -- New long-term data...
Results from Radiographic Analyses Show Efficacy of SIMPONI in Inhibiting Joint Destruction in Two Rheumatic Conditions PHILADELPHIA, Oct. 19 /PRNewswire/ -- Phase 3 data reported for the first...
NEW BRUNSWICK, N.J., Oct. 6 /PRNewswire-FirstCall/ -- Johnson & Johnson will host an analyst meeting at 8:30 a.m. (Eastern Time) on Tuesday, Oct. 13, 2009, to discuss third-quarter financial...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 5.06 | 3.6650731566 | 138.06 | 144.3 | 137.72 | 10188 | 140.9196305 | DE |
4 | 4.6 | 3.32082009818 | 138.52 | 144.3 | 137.22 | 10805 | 139.6422189 | DE |
12 | -7.94 | -5.25618959354 | 151.06 | 151.68 | 136.52 | 9414 | 142.48522671 | DE |
26 | 4.12 | 2.96402877698 | 139 | 153.97999 | 135.84 | 8863 | 144.98885847 | DE |
52 | -4.38 | -2.96949152542 | 147.5 | 153.97999 | 132.74 | 9329 | 142.86410521 | DE |
156 | -4.38 | -2.96949152542 | 147.5 | 178.26 | 132.74 | 6182 | 148.11171701 | DE |
260 | 9.72 | 7.28635682159 | 133.4 | 178.26 | 104.12 | 7701 | 139.88462875 | DE |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions